/USNA
USNA Stock - USANA Health Sciences, Inc.
Consumer Defensive|Packaged FoodsNYSE
$19.92-2.11%
$0.43 (-2.11%) • Dec 19
69
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.19
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).100
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.94
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+144.7%upside
Target: $48.74
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for USNA
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$19.72 – $20.12
TARGET (TP)$48.75
STOP LOSS$18.33
RISK/REWARD1:18.1
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.65
52W High$38.32
52W Low$18.48
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $854.50M | $921.01M | $998.60M | $1.19B | $1.13B |
| Gross Profit | $693.29M | $744.32M | $804.71M | $968.57M | $925.53M |
| Gross Margin | 81.1% | 80.8% | 80.6% | 81.6% | 81.6% |
| Operating Income | $66.32M | $93.07M | $107.61M | $170.19M | $176.49M |
| Net Income | $42.03M | $63.79M | $69.35M | $116.50M | $124.66M |
| Net Margin | 4.9% | 6.9% | 6.9% | 9.8% | 11.0% |
| EPS | $2.20 | $3.33 | $3.60 | $5.78 | $5.89 |
Company Overview
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products directly in the Asia Pacific, the Americas, and Europe, as well as online. The company has a research collaboration agreement with Beijing University of Chinese Medicine for research in the field of traditional Chinese medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
1
33%
Hold / Neutral
1
33%
Sell / Underperform
1
33%
Analyst Consensus🔴 Bearish
1 Bullish2 Neutral/Bearish
Price Targets
$70
Average Target
↑ 248.9% Upside
Now
$53
Low
$70
Average
$86
High
Based on 2 analysts
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| June 23rd 2023 | Sidoti | Initiation | Buy | - |
| July 7th 2022 | Jefferies | Downgrade | Underperform | $53← $78 |
| April 14th 2022 | DA Davidson | Initiation | Neutral | $86 |
Earnings History & Surprises
USNABeat Rate
67%
Last 18 quarters
Avg Surprise
+5.7%
EPS vs Estimate
Beats / Misses
12/6
Last 12 quarters
Latest EPS
$-0.15
Q4 2025
EPS Surprise History
Q1 24
+67.3%
$0.87vs$0.52
Q2 24
+24.6%
$0.86vs$0.69
Q3 24
-16.9%
$0.54vs$0.65
Q4 24
+14.3%
$0.56vs$0.49
Q1 25
+30.6%
$0.64vs$0.49
Q2 25
+4.3%
$0.73vs$0.70
Q3 25
+37.0%
$0.74vs$0.54
Q4 25
-160.0%
$-0.15vs$0.25
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 20, 2026 | — | — | — | — |
Q1 2026 | Feb 24, 2026 | $0.40 | — | — | — |
Q4 2025 | Oct 21, 2025 | $0.25 | $-0.15 | -160.0% | ✗ MISS |
Q3 2025 | Jul 22, 2025 | $0.54 | $0.74 | +37.0% | ✓ BEAT |
Q2 2025 | Apr 22, 2025 | $0.70 | $0.73 | +4.3% | ✓ BEAT |
Q1 2025 | Feb 25, 2025 | $0.49 | $0.64 | +30.6% | ✓ BEAT |
Q4 2024 | Oct 22, 2024 | $0.49 | $0.56 | +14.3% | ✓ BEAT |
Q3 2024 | Jul 23, 2024 | $0.65 | $0.54 | -16.9% | ✗ MISS |
Q2 2024 | Apr 30, 2024 | $0.69 | $0.86 | +24.6% | ✓ BEAT |
Q1 2024 | Feb 6, 2024 | $0.52 | $0.87 | +67.3% | ✓ BEAT |
Q4 2023 | Oct 24, 2023 | $0.64 | $0.59 | -7.8% | ✗ MISS |
Q3 2023 | Jul 25, 2023 | $0.70 | $0.89 | +27.1% | ✓ BEAT |
Q2 2023 | Apr 25, 2023 | $0.77 | $0.95 | +23.4% | ✓ BEAT |
Q1 2023 | Feb 7, 2023 | $0.35 | $0.66 | +88.6% | ✓ BEAT |
Q4 2022 | Oct 25, 2022 | $0.89 | $0.78 | -12.4% | ✗ MISS |
Q3 2022 | Jul 26, 2022 | $1.14 | $1.00 | -12.3% | ✗ MISS |
Q2 2022 | Apr 26, 2022 | $1.14 | $1.15 | +0.9% | ✓ BEAT |
Q1 2022 | Feb 8, 2022 | $1.28 | $1.03 | -19.5% | ✗ MISS |
Q4 2021 | Oct 26, 2021 | $1.30 | $1.36 | +4.6% | ✓ BEAT |
Q3 2021 | Jul 27, 2021 | $1.72 | $1.87 | +8.7% | ✓ BEAT |
Latest News
USANA's Probiotic Supplement Earns Consumerlab.com Seal Of Approval
📈 PositiveBenzinga•Dec 16, 2025, 12:22 PM
•Solstice Advance Materials Will Replace CarMax In The S&P 500, And CarMax Will Replace USANA Health Sciences In The S&P SmallCap 600 Effective Prior To The Opening Of Trading On Friday, October 31
📈 PositiveBenzinga•Oct 27, 2025, 09:21 PM•Also: , ,
USANA Health Sciences shares are trading lower after the company lowered its FY25 guidance.
📉 NegativeBenzinga•Oct 22, 2025, 08:08 PM
Usana Health Sciences Lowers FY2025 Adj EPS Guidance from $2.35-$3.00 to $1.73 vs $1.70 Est; Narrows FY2025 Sales Guidance from $920.000M-$1.000B to $920.000M vs $919.587M Est
📉 NegativeBenzinga•Oct 22, 2025, 08:06 PM
Usana Health Sciences Q3 Adj. EPS $(0.15) Misses $0.37 Estimate, Sales $213.670M Miss $220.324M Estimate
📉 NegativeBenzinga•Oct 22, 2025, 08:05 PM
USANA Health Sciences shares are trading lower after the company issued Q3 preliminary financial results below estimates.
📉 NegativeBenzinga•Oct 10, 2025, 01:08 PM
Usana Health Sciences Sees Q3 Adj EPS $(0.15) vs $0.47 Est; Sees Sales $214.000M vs $224.128M Est
📉 NegativeBenzinga•Oct 9, 2025, 09:12 PM
Usana Health Sciences Sees Q3 GAAP EPS $(0.36) vs $0.44 Est
📉 NegativeBenzinga•Oct 9, 2025, 09:11 PM
USANA Health Sciences Says In Q3 Saw Softer-than-expected Sales, Brand Partner Productivity During Rollout Of Enhanced Brand Partner; Slowdown During Transition Was More Pronounced Than Anticipated And Negatively Affected Our Quarterly Results; Expect Sales For Full Year To Be At Or Near Lower End Of Our Previously Issued Full-Year Outlook Range; Expect Earnings Per Share To Be Below Previously Issued Full-Year Outlook Range
📉 NegativeBenzinga•Oct 9, 2025, 08:23 PM
USANA Health Sciences shares fall on prelim Q3 results
📉 NegativeSeeking Alpha•Oct 9, 2025, 08:19 PM
USANA Health Sciences shares are trading lower. The company reported preliminary Q3 financial results.
📉 NegativeBenzinga•Oct 9, 2025, 08:18 PM
USANA Health Sciences Anticipates Q3 2025 Adj. EPS $(0.15) Up From $0.56 YoY; Net Sales Will Be ~$214M Up From $200M YoY
➖ NeutralBenzinga•Oct 9, 2025, 08:09 PM
USANA Unveils New And Upgraded Nutritionals, Celavive Skincare, And Launches Health Professional Advisory Council At 2025 Global Convention
📈 PositiveBenzinga•Aug 22, 2025, 11:10 AM
Frequently Asked Questions about USNA
What is USNA's current stock price?
USANA Health Sciences, Inc. (USNA) is currently trading at $19.92 per share. The stock has moved -2.11% today.
What is the analyst price target for USNA?
The average analyst price target for USNA is $48.75, based on 1 analyst.
What sector is USANA Health Sciences, Inc. in?
USANA Health Sciences, Inc. operates in the Consumer Defensive sector, specifically within the Packaged Foods industry. The company is traded on the NYSE exchange.
What is USNA's market cap?
USANA Health Sciences, Inc. has a market capitalization of $0.36 billion, making it a small-cap company.
Does USNA pay dividends?
No, USANA Health Sciences, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Consumer Defensive SectorBGS
B&G Foods, Inc.
$4.58
Mkt Cap: $0.4B
BRCC
BRC Inc.
$1.26
Mkt Cap: $0.1B
CVGW
Calavo Growers, Inc.
$22.07
Mkt Cap: $0.4B
DDL
Dingdong (Cayman) Limited
$2.54
Mkt Cap: $0.6B
LND
BrasilAgro - Companhia Brasileira de Propriedades Agrícolas
$3.58
Mkt Cap: $0.4B
LWAY
Lifeway Foods, Inc.
$23.63
Mkt Cap: $0.4B
MAMA
Mama's Creations, Inc.
$14.06
Mkt Cap: $0.5B
QSG
QuantaSing Group Ltd
$5.17
Mkt Cap: $0.3B
VSTA
Vasta Platform Limited
$4.98
Mkt Cap: $0.4B
WEST
Westrock Coffee Company, LLC
$4.19
Mkt Cap: $0.4B
Explore stocks similar to USNA for comparison